Roche Q3 Sales Rise 8% in Swiss Francs as Pharma Beats Forecast
Photo: TokenPost
Roche’s third-quarter Group sales rose 8% in Swiss francs from a year earlier to CHF 16.13 billion, topping the CHF 15.752 billion consensus estimate. At constant exchange rates, sales growth was 7%. The Pharmaceuticals Division recorded CHF 12.583 billion in sales for the quarter, CHF 350 million above its CHF 12.233 billion consensus forecast. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
![[Satoshi Index] Seven-Day Top Crypto Traders Edge From 8% to 11% Long Since the Morning Edition; All Three Groups Still About 90% Short](/img/p591cj1qwhfs.jpg)
